Mark Velleca
InvestorVenture Partner at Hatteras Venture Partners
Durham, North Carolina
Writes $100K – $5M checks · typically $1.5M
FoundedG1 Therapeutics
Experience
- Black Diamond TherapeuticsCEOcurrent2023 — present
- Black Diamond TherapeuticsBoard Chaircurrent2022 — present
- Black Diamond TherapeuticsBoard Director2021 — 2022
- iOncturaBoard Chaircurrent2024 — present
- CREATE MedicinesBoard Directorcurrent2023 — present
- G1 Therapeutics, Inc.Board Director, Senior Advisor2021 — 2024
- Hatteras Venture PartnersVenture Partner2021 — 2023
- StrideBio, IncAdvisor, CEO, Board Director2021 — 2023
- IMMvention Therapeutix, Inc.Board Chair2021 — 2023
- G1 Therapeutics, Inc.CEO, Board Director2014 — 2020
- Yale University School of MedicineAssistant Clinical Professor (adjunct)1999 — 2017
- Yale University School of MedicineAssociate Research Scientist1997 — 1999
- The Leukemia & Lymphoma SocietyChief Policy and Advocacy Officer2012 — 2014
- Gilead SciencesSenior Advisor2010 — 2012
- CGI Pharmaceuticals, Inc.Founder and SVP1999 — 2010
- Yale New Haven HospitalResident, Chief Resident, Fellow, Attending Physician1995 — 2002
- Yale UniversityResearch Assistant1985 — 1987
Education
- Washington University in St. LouisM.D., Ph.D.1987 — 1995
- Yale UniversityB.S., Cum Laude1981 — 1985
- Hopkins School1975 — 1981
Deals · 1
IMMvention TherapeutixBoard seat
via Hatteras Venture Partners · filed Jan 2023 · $4M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Hatteras Venture Partners
Alston Gardner
Special Advisor at Hatteras Venture Partners
Ben Scruggs
Partner at Hatteras Venture Partners
Ben Scruggs, PhD
Partner at Hatteras Venture Partners
Christy Shaffer
General Partner at Hatteras Venture Partners
Christy Shaffer, PhD
General Partner at Hatteras Venture Partners
Clay Thorp
General Partner at Hatteras Venture Partners
Declan Devens
Operations Analyst at Hatteras Venture Partners
Don Rose
Venture Partner at Hatteras Venture Partners
Frequently asked questions
- Where does Mark Velleca work?
- Mark Velleca is Venture Partner at Hatteras Venture Partners.
- What check size does Mark Velleca write?
- Mark Velleca typically writes checks of $100K – $5M.
- What companies did Mark Velleca found?
- Mark Velleca founded G1 Therapeutics.
Same school
Also attended Washington University in St. Louis164
Lee FixelFounder of AdditionMax WechterSenior Director of AI at Lerer HippeauMark LevinRetired Founding Partner at Third Rock VenturesAndrew ForysiakOwner, AJF and Associates at Riphean InvestmentsRochelle WalenskyExecutive Partner at Flare Capital PartnersMitzi KrockoverInvestor at Golden Seeds
+ 158 more
Also attended Yale University622
Ann Miura-KoCo-founding Partner at FloodgateDavid SzeAdvisory Partner at GreylockMichael SeibelPartner Emeritus at Y CombinatorZheela QaiserInvestor at Index VenturesAnthony PhilippakisInvestor at GV (Google Ventures)Karthik ArdhanareeswaranInvestor at GV (Google Ventures)
+ 616 more
Also attended Hopkins School19
Kevin ColleranManaging Director at Slow VenturesMark XuInvestor at Index VenturesMike DudasInvestor at 6th Man VenturesEmilio Maglione-FulcoHead of Operations at 6th Man VenturesMatt VineSenior Associate at RRE VenturesKeith GiarmanExecutive Coach & Recruiting at Roble Ventures
.png)
+ 13 more
Shared employers
Also worked at iOnctura7
Diego BragugliaManaging Partner at VI PartnersKeno GutierrezGeneral Partner at BioGeneration VenturesHakan GokerManaging Director at M VenturesThijs Cohen TervaertPartner at InkefPaolo FundaròFounder and Managing Partner at XGEN VentureRoberto De PontiSenior Advisor at Claris Ventures
+ 1 more
Also worked at StrideBio, Inc1
Also worked at Gilead Sciences23
Uri LopatinInvestor at Khosla VenturesJay ParrishVenture Partner at ARCH Venture PartnersPatrick LoerchBio Advisor at Amplify PartnersLan WuAnalyst at FusionAriel RahamimPrincipal at Concept VenturesMuz MansuriAdvisor at Delin Ventures
.png)
+ 17 more
